These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11721696)

  • 1. Effects of prolactin on hematopoiesis.
    Welniak LA; Richards SM; Murphy WJ
    Lupus; 2001; 10(10):700-5. PubMed ID: 11721696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem/progenitor cells express several functional sex hormone receptors-novel evidence for a potential developmental link between hematopoiesis and primordial germ cells.
    Mierzejewska K; Borkowska S; Suszynska E; Suszynska M; Poniewierska-Baran A; Maj M; Pedziwiatr D; Adamiak M; Abdel-Latif A; Kakar SS; Ratajczak J; Kucia M; Ratajczak MZ
    Stem Cells Dev; 2015 Apr; 24(8):927-37. PubMed ID: 25607657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin: structure, function, and regulation of secretion.
    Freeman ME; Kanyicska B; Lerant A; Nagy G
    Physiol Rev; 2000 Oct; 80(4):1523-631. PubMed ID: 11015620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of arachidonic acid in normal and malignant hematopoiesis.
    Rizzo MT
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):57-69. PubMed ID: 12051957
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematopoietic stem cell proliferation modeling under the influence of hematopoietic-inducing agent.
    Antoniou ES; Mouser CL; Rosar ME; Tadros J; Vassiliou EK
    Shock; 2009 Nov; 32(5):471-7. PubMed ID: 19295494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone and prolactin on hematopoiesis.
    Welniak LA; Tian ZG; Sun R; Keller JR; Richards S; Ruscetti FW; Murphy WJ
    Leuk Lymphoma; 2000 Aug; 38(5-6):435-45. PubMed ID: 10953965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells.
    Bellone G; Geuna M; Carbone A; Silvestri S; Foa R; Emanuelli G; Matera L
    J Cell Physiol; 1995 May; 163(2):221-31. PubMed ID: 7535779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor and hematopoiesis.
    Allouche M
    Leukemia; 1995 Jun; 9(6):937-42. PubMed ID: 7596180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instruction of hematopoietic lineage choice by cytokine signaling.
    Endele M; Etzrodt M; Schroeder T
    Exp Cell Res; 2014 Dec; 329(2):207-13. PubMed ID: 25046868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallels between immune driven-hematopoiesis and T cell activation: 3 signals that relay inflammatory stress to the bone marrow.
    Libregts SF; Nolte MA
    Exp Cell Res; 2014 Dec; 329(2):239-47. PubMed ID: 25246130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of proliferation and differentiation of the hematopoietic cell precursors during regeneration of hematopoiesis in cytostatic myelosuppression].
    Dygaĭ AM; Zhdanov VV; Minakova MIu; Ryzhakov VM; Gol'dberg ED
    Biull Eksp Biol Med; 1997 Dec; 124(12):616-20. PubMed ID: 9483310
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells.
    Dogusan Z; Book ML; Verdood P; Yu-Lee LY; Hooghe-Peters EL
    Eur Cytokine Netw; 2000 Sep; 11(3):435-42. PubMed ID: 11022129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH; Miller KK; Schuler LA
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin (PRL)--multifunctional, hypophyseal peptide hormone].
    Michalik J; Bartoszewicz Z
    Postepy Biochem; 2002; 48(4):296-305. PubMed ID: 12731395
    [No Abstract]   [Full Text] [Related]  

  • 15. Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor.
    Das R; Vonderhaar BK
    Mol Endocrinol; 1995 Dec; 9(12):1750-9. PubMed ID: 8614411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function.
    Richards SM; Murphy WJ
    J Neuroimmunol; 2000 Sep; 109(1):56-62. PubMed ID: 10969182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil.
    Pospísil M; Hofer M; Vacek A; Znojil V; Pipalová I
    Physiol Res; 2004; 53(5):549-56. PubMed ID: 15479134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of prolactin receptor antagonist to better understand prolactin regulation of pituitary homeostasis.
    Ferraris J; Bernichtein S; Pisera D; Goffin V
    Neuroendocrinology; 2013; 98(3):171-9. PubMed ID: 23969780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression.
    Ferraris J; Boutillon F; Bernadet M; Seilicovich A; Goffin V; Pisera D
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E356-64. PubMed ID: 22094470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.
    Zhang QS; Deater M; Schubert K; Marquez-Loza L; Pelz C; Sinclair DA; Grompe M
    Stem Cell Res; 2015 Jul; 15(1):130-40. PubMed ID: 26046330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.